] . 2018. “Preliminary Aggregate Safety And Immunogenicity Results From Three Trials Of A Purified Inactivated Zika Virus Vaccine Candidate: Phase 1, Randomised, Double-Blind, Placebo-Controlled Clinical Trials.”. Lancet 391 (10120). Lancet: 563-571. doi:10.1016/S0140-6736(17)33106-9.